A Phase IB/II Single-arm Study of M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas
Phase of Trial: Phase I/II
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Gemcitabine (Primary) ; MSB 0011359C (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Aug 2018 Status changed from recruiting to suspended as the study is undergoing sponsor audit
- 17 May 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 May 2018 to 23 May 2018.
- 26 Apr 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 18 Apr 2018 to 1 May 2018.